Skip to main content
. Author manuscript; available in PMC: 2020 May 13.
Published in final edited form as: Curr HIV Res. 2017;15(6):411–421. doi: 10.2174/1570162X15666171120110145

Fig. (1).

Fig. (1).

(A) HIV-1 infection pathway and (B) Antiretroviral drug (ARV) action site. The numbers in part (A), describes the ARVs target action site of part (B). vRNA, viral RNA genome; vDNA, complimentary viral DNA.